GOVERNMENT ADVISORY BODY
KMF REPRESENTATION TO THE AUSTRALIAN DEPARTMENT OF HEALTH
The Karl McManus Foundation (KMF) met with the Chief Medical Officer of Australia, Professor Chris Baggoley, in November 2012. Following this meeting, a Clinical Advisory Committee was formed to provide Professor Baggoley with advice on the evidence of Lyme borreliosis in Australia.
Members of the Clinical Advisory Committee on Lyme Disease (CACLD) at Scarborough House Canberra, 19 Mar 2013.
The CACLD held its first meeting on 19 March 2013, the first of five to date.
The Terms of Reference for the CACLD can be viewed at the Australian Department of Health’s website.
The purpose of the CACLD is to provide advice to the Chief Medical Officer of Australia on:
- Evidence of Borrelia species causing illness in humans in Australia.
- Appropriate laboratory diagnostic testing algorithms (best world practice) for persons who have suspected borreliosis in Australia.
- Appropriate treatments for borreliosis in Australia.
- Ways to disseminate information to health professionals and the general public on borreliosis/Lyme disease.
- Research requirements into borreliosis in Australia
- Other questions relevant to the terms of reference
The KMF’s directors have been active in contributing to the evidence of Borrelia in Australia, and alerting health authorities/government to the urgency of resolving this issue that was first raised in the 1990s.
DIAGNOSTIC PATHWAY WORKING GROUP
AUGUST 2014 - FINAL PROGRESS REPORT
The last official CACLD progress report against each term of reference can be viewed. CMO Professor Chris Baggoley outlines the way forward for the Department of Health in its continued involvement to progress the work of the CACLD.
Advice provided by the CACLD, recommendations from the Scoping Study and outcomes from the Lyme Disease Round Table Meeting have resulted in a list of potential research projects that would assist in clarifying the Australian Lyme disease-like syndrome. View consolidated list of research projects.
JULY 2014 – LAST OFFICIAL CACLD MEETING AND RESPONSE TO SCOPING STUDY
JULY 2014 - MEDIA STATEMENT
Read statement here.
MAY 2014 - ROUND TABLE MEETING
MAY 2014 - PATHOLOGIST MEETING
SEPTEMBER 2013 - SCOPING STUDY
The study covers key issues such as evidence, research that needs to be undertaken to provide DNA evidence of Borrelia in Australian ticks and reservoir animals, diagnostic options available for Australia and clinical trials that can help to address the treatment of Australian Lyme-like illness.
AUGUST 2013 - CHIEF MEDICAL OFFICER’S ADVICE TO CLINICIANS
Growing evidence of an emerging tick-borne disease that causes a Lyme like illness for many Australian patients
On 12 November 2015, the Senate referred the following matter to the Senate Community Affairs References Committee for inquiry and report:
The growing evidence of an emerging tick-borne disease that causes a Lyme‑like illness for many Australian patients.